• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雄激素、雄激素受体、抗雄激素药物与前列腺癌的治疗

Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer.

作者信息

Griffiths K, Morton M S, Nicholson R I

机构信息

Tenovus Cancer Research Centre, University of Wales College of Medicine, Cardiff, UK.

出版信息

Eur Urol. 1997;32 Suppl 3:24-40.

PMID:9267783
Abstract

Androgens play a major role in promoting the growth of the prostate gland. The DHT-androgen receptor complex, by association with the androgen response elements, specifically promotes this androgenic effect on the genome. Also recognized now, however, is that there is a close relationship between this androgen-mediated signalling pathway and those promoted by peptide growth factors, the crosstalk between the pathways being pivotal to growth regulatory control. This is discussed together with the perceived clinical potential of tyrosine kinase inhibitors for the treatment of prostate cancer, when the intracellular signalling, induced by the growth stimulatory factors, can be repressed.

摘要

雄激素在促进前列腺生长中起主要作用。双氢睾酮 - 雄激素受体复合物通过与雄激素反应元件结合,特异性地促进这种对基因组的雄激素效应。然而,现在也认识到,这种雄激素介导的信号通路与肽生长因子所促进的信号通路之间存在密切关系,这些通路之间的相互作用对于生长调节控制至关重要。当生长刺激因子诱导的细胞内信号传导可以被抑制时,本文将结合酪氨酸激酶抑制剂在治疗前列腺癌方面的潜在临床应用对此进行讨论。

相似文献

1
Androgens, androgen receptors, antiandrogens and the treatment of prostate cancer.雄激素、雄激素受体、抗雄激素药物与前列腺癌的治疗
Eur Urol. 1997;32 Suppl 3:24-40.
2
Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.双氢睾酮与表皮生长因子受体/丝裂原活化蛋白激酶信号通路相互作用,并调节雄激素受体阳性的LNCaP前列腺癌细胞中的表皮生长因子受体水平。
Int J Oncol. 2008 Sep;33(3):623-9.
3
Androgen sensitivity related proteins in hormone-sensitive and hormone-insensitive prostate cancer cell lines treated by androgen antagonist bicalutamide.雄激素拮抗剂比卡鲁胺处理的激素敏感型和激素不敏感型前列腺癌细胞系中的雄激素敏感性相关蛋白
Neoplasma. 2001;48(5):419-24.
4
Sustained in vivo regression of Dunning H rat prostate cancers treated with combinations of androgen ablation and Trk tyrosine kinase inhibitors, CEP-751 (KT-6587) or CEP-701 (KT-5555).用雄激素去除与Trk酪氨酸激酶抑制剂CEP-751(KT-6587)或CEP-701(KT-5555)联合治疗的Dunning H大鼠前列腺癌在体内持续消退。
Cancer Res. 1999 May 15;59(10):2395-401.
5
The role of DOC-2/DAB2 in modulating androgen receptor-mediated cell growth via the nongenomic c-Src-mediated pathway in normal prostatic epithelium and cancer.DOC-2/DAB2在正常前列腺上皮和癌症中通过非基因组c-Src介导的途径调节雄激素受体介导的细胞生长中的作用。
Cancer Res. 2005 Nov 1;65(21):9906-13. doi: 10.1158/0008-5472.CAN-05-1481.
6
Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.前列腺癌细胞中的雄激素受体信号传导与维生素D受体作用
Prostate. 2005 Sep 1;64(4):362-72. doi: 10.1002/pros.20251.
7
Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells.雄激素受体对核因子κB信号传导的阻断促进了12-O-十四烷酰佛波醇-13-乙酸酯诱导的雄激素敏感性前列腺癌LNCaP细胞凋亡。
Cancer Res. 2003 Nov 1;63(21):7106-12.
8
Enhanced androgen receptor signaling correlates with the androgen-refractory growth in a newly established MDA PCa 2b-hr human prostate cancer cell subline.在新建立的MDA PCa 2b-hr人前列腺癌细胞亚系中,增强的雄激素受体信号传导与雄激素难治性生长相关。
Cancer Res. 2003 Sep 1;63(17):5622-8.
9
Androgen receptor: role and novel therapeutic prospects in prostate cancer.雄激素受体:在前列腺癌中的作用及新的治疗前景
Expert Rev Anticancer Ther. 2008 Sep;8(9):1495-508. doi: 10.1586/14737140.8.9.1495.
10
Interaction between protein tyrosine phosphatase and protein tyrosine kinase is involved in androgen-promoted growth of human prostate cancer cells.蛋白质酪氨酸磷酸酶与蛋白质酪氨酸激酶之间的相互作用参与雄激素促进的人前列腺癌细胞生长。
Oncogene. 2000 May 18;19(22):2664-77. doi: 10.1038/sj.onc.1203576.

引用本文的文献

1
Elevated periprostatic androgens, sneaky testosterone and its implications.前列腺周雄激素升高、狡猾的睾酮及其影响
Nat Rev Urol. 2024 Dec;21(12):754-760. doi: 10.1038/s41585-024-00878-8. Epub 2024 May 7.
2
Genetically elevated bioavailable testosterone level was associated with the occurrence of benign prostatic hyperplasia.遗传导致的生物可利用睾酮水平升高与良性前列腺增生的发生有关。
J Endocrinol Invest. 2023 Oct;46(10):2095-2102. doi: 10.1007/s40618-023-02060-0. Epub 2023 Mar 13.
3
Neferine improves oxidative stress and apoptosis in benign prostate hyperplasia via Nrf2-ARE pathway.
小檗碱通过 Nrf2-ARE 通路改善良性前列腺增生中的氧化应激和细胞凋亡。
Redox Rep. 2021 Dec;26(1):1-9. doi: 10.1080/13510002.2021.1871814.
4
Regulation of HMGB3 by antitumor miR-205-5p inhibits cancer cell aggressiveness and is involved in prostate cancer pathogenesis.抑癌 miR-205-5p 通过调控 HMGB3 抑制肿瘤细胞侵袭能力并参与前列腺癌的发病机制。
J Hum Genet. 2018 Feb;63(2):195-205. doi: 10.1038/s10038-017-0371-1. Epub 2017 Dec 1.
5
Characterization of reactive stroma in prostate cancer: involvement of growth factors, metalloproteinase matrix, sexual hormones receptors and prostatic stem cells.前列腺癌中反应性基质的特征:生长因子、金属蛋白酶基质、性激素受体及前列腺干细胞的作用
Int Braz J Urol. 2015 Sep-Oct;41(5):849-58. doi: 10.1590/S1677-5538.IBJU.2014.0355.
6
Characterization of tumor differentiation factor (TDF) and its receptor (TDF-R).肿瘤分化因子(TDF)及其受体(TDF-R)的特征。
Cell Mol Life Sci. 2013 Aug;70(16):2835-48. doi: 10.1007/s00018-012-1185-0. Epub 2012 Oct 18.
7
Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol.雄激素非依赖性前列腺癌细胞具备从胆固醇合成睾酮的完整类固醇生成能力。
Mol Cell Endocrinol. 2008 Nov 25;295(1-2):115-20. doi: 10.1016/j.mce.2008.08.013. Epub 2008 Aug 20.
8
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance.激素治疗期间人前列腺癌的基因表达分析可识别雄激素反应性基因及治疗抗性机制。
Am J Pathol. 2004 Jan;164(1):217-27. doi: 10.1016/S0002-9440(10)63112-4.